Walgreens Boots Alliance Inc

WBA: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$88.00FtdgByhl

Walgreens Provides Solid 2023 Outlook, Despite Headwinds Kicking In During Fourth Quarter

Although no-moat Walgreens Boots Alliance reported weak fiscal 2022 fourth-quarter results relative to last year, it delivered ahead of fiscal-year expectations. We plan to mildly adjust our long-term assumptions to better account for likely growth in the U.S. healthcare segment but expect to maintain our $48 fair value estimate at first glance. The shares appear significantly undervalued to us.

Sponsor Center